International: IACFS/ME - International Association for CFS/ME, IACFSME

[Hutan]

From an email:

The Board is delighted to announce that H. Timothy "Tim" Hsiao will be joining the IACFS/ME Board! Thank you to all Professional IACFS/ME Members for voting and for your comments.

Since last Fall, Dr. Hsiao has been attending Board meetings and participating in IACFS/ME-related activities. Tim has been helping us to reach out to new members, comply with US non-profit regulations, and organize a special event for researchers at our upcoming Conference (stay tune!). He brings with him a wealth of experience in science and science administration. Please see below for more information about Dr. Hsiao.

Please join us in welcoming Dr. Hsiao to the Board!

Sincerely,

IACFS/ME

Tim is a Senior Innovation Strategy & Management Advisor at AVANTIQOR (a consulting firm), currently supporting the Advanced Research Projects Agency for Health (ARPA-H) in Washington, DC. Previously, he served as the Chief Scientific Officer of Solve M.E., Director of the Department of Scientific Affairs at the American Society for Radiation Oncology, and Program Director at the National Center for Advancing Translational Sciences (NCATS, part of the NIH). Tim holds a PhD in Molecular Biophysics & Biochemistry from Yale University and has been recognized by awards such as the NIH Director’s Award and the NCATS Director’s Award.

Why I Volunteer:

Tackling complex chronic diseases takes a whole village. I hope to support the IACFS/ME to continue convening all stakeholders in the ecosystem to effectively share knowledge and collaborate to advance medical research and bring hope to our fellow global citizens who are impacted by ME/CFS, Long COVID, and other related disorders.

 

[Dolphin]

Legitimizing fatigue in medicine and disease: The challenge of a fatigue journal

By Dr. Fred Friedberg, PhD The first biomedical fatigue journal, Fatigue: Biomedicine, Health and Behavior, is a peer review quarterly, and the official journal of the IACFS/ME.

www.linkedin.com

Legitimizing fatigue in medicine and disease: The challenge of a fatigue journal​

International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME)​

352 followers



July 17, 2025
By Dr. Fred Friedberg, PhD

The first biomedical fatigue journal, Fatigue: Biomedicine, Health and Behavior, is a peer review quarterly, and the official journal of the IACFS/ME. We’ve been publishing now for 12 years as a subscription journal of Taylor and Francis. Papers cover a wide range of topics including fatigue originating from disease (e.g., Long COVID; chronic fatigue syndrome (ME/CFS); cancer), aging, occupations, and athletics/sports. The thorny problem of identifying effective treatments without clear understanding of the causes and persistence of fatigue is a challenge taken up by many of our authors and investigators.

For instance, our top downloaded article in the last 12 months was: “Stellate Ganglion Block reduces symptoms of SARS-CoV-2-induced ME/CFS: A prospective cohort pilot study.” The top cited article was: “Measuring and understanding the health impact of greater fatigability in older adults: A call to action and opportunities.”

Articles on post-exertional symptoms have also received a lot of attention from readers. A highly cited article of the last 2 years was: “Post-exertional malaise may persist in Long COVID despite learning STOP-REST-PACE.” The top Altmetric score goes to: “Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive therapy? A critical commentary and preliminary re-analysis of the PACE trial.” The Altmetric score reflects the amount of online attention a research paper (or book) has received from various sources including citations, news articles, blog posts, social media, policy documents and more.

For submissions to the Fatigue journal, the average time to an initial decision for a submitted paper is 30 days. Our current impact factor is 2.2. As a subscription journal, there are no publishing fees, unless the authors opt for open access. For further information on submitting a paper, see https://www.tandfonline.com/loi/rftg20.

Professional IACFS/ME members receive online access to the journal as part of their membership and Associate IACFS/ME members receive a deep discount off of the usual subscription cost. For more information about how to join IACFS/ME, see this webpage.

#mecfs #longcovid #researchanddevelopment #chronicillness #chronicfatiguesyndrome #myalgicencephalomyelitis